These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 2724296

  • 1. Effects of 8-phenyl and 8-cycloalkyl substituents on the activity of mono-, di-, and trisubstituted alkylxanthines with substitution at the 1-, 3-, and 7-positions.
    Shamim MT, Ukena D, Padgett WL, Daly JW.
    J Med Chem; 1989 Jun; 32(6):1231-7. PubMed ID: 2724296
    [Abstract] [Full Text] [Related]

  • 2. Analogues of caffeine and theophylline: effect of structural alterations on affinity at adenosine receptors.
    Daly JW, Padgett WL, Shamim MT.
    J Med Chem; 1986 Jul; 29(7):1305-8. PubMed ID: 3806581
    [Abstract] [Full Text] [Related]

  • 3. Xanthine derivatives as antagonists at A1 and A2 adenosine receptors.
    Schwabe U, Ukena D, Lohse MJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Sep; 330(3):212-21. PubMed ID: 2997628
    [Abstract] [Full Text] [Related]

  • 4. 7-Deaza-2-phenyladenines: structure-activity relationships of potent A1 selective adenosine receptor antagonists.
    Müller CE, Hide I, Daly JW, Rothenhäusler K, Eger K.
    J Med Chem; 1990 Oct; 33(10):2822-8. PubMed ID: 2213835
    [Abstract] [Full Text] [Related]

  • 5. N6-substituted 9-methyladenines: a new class of adenosine receptor antagonists.
    Ukena D, Padgett WL, Hong O, Daly JW, Daly DT, Olsson RA.
    FEBS Lett; 1987 May 11; 215(2):203-8. PubMed ID: 3582647
    [Abstract] [Full Text] [Related]

  • 6. 1,3-Dialkyl-8-(p-sulfophenyl)xanthines: potent water-soluble antagonists for A1- and A2-adenosine receptors.
    Daly JW, Padgett W, Shamim MT, Butts-Lamb P, Waters J.
    J Med Chem; 1985 Apr 11; 28(4):487-92. PubMed ID: 2984420
    [Abstract] [Full Text] [Related]

  • 7. 8-Aryl-and 8-cycloalkyl-1,3-dipropylxanthines: further potent and selective antagonists for A1-adenosine receptors.
    Shamim MT, Ukena D, Padgett WL, Hong O, Daly JW.
    J Med Chem; 1988 Mar 11; 31(3):613-7. PubMed ID: 3346878
    [Abstract] [Full Text] [Related]

  • 8. Adenosine receptors: development of selective agonists and antagonists.
    Daly JW, Jacobson KA, Ukena D.
    Prog Clin Biol Res; 1987 Mar 11; 230():41-63. PubMed ID: 3588607
    [Abstract] [Full Text] [Related]

  • 9. Structure-activity relationships of 8-cycloalkyl-1,3-dipropylxanthines as antagonists of adenosine receptors.
    Katsushima T, Nieves L, Wells JN.
    J Med Chem; 1990 Jul 11; 33(7):1906-10. PubMed ID: 1694546
    [Abstract] [Full Text] [Related]

  • 10. Analogs of caffeine: antagonists with selectivity for A2 adenosine receptors.
    Ukena D, Shamim MT, Padgett W, Daly JW.
    Life Sci; 1986 Aug 25; 39(8):743-50. PubMed ID: 3016449
    [Abstract] [Full Text] [Related]

  • 11. Adenosine receptor-blocking xanthines as inhibitors of phosphodiesterase isozymes.
    Ukena D, Schudt C, Sybrecht GW.
    Biochem Pharmacol; 1993 Feb 24; 45(4):847-51. PubMed ID: 7680859
    [Abstract] [Full Text] [Related]

  • 12. Species differences in structure-activity relationships of adenosine agonists and xanthine antagonists at brain A1 adenosine receptors.
    Ukena D, Jacobson KA, Padgett WL, Ayala C, Shamim MT, Kirk KL, Olsson RO, Daly JW.
    FEBS Lett; 1986 Dec 01; 209(1):122-8. PubMed ID: 3803571
    [Abstract] [Full Text] [Related]

  • 13. 8-Azaxanthine derivatives as antagonists of adenosine receptors.
    Franchetti P, Messini L, Cappellacci L, Grifantini M, Lucacchini A, Martini C, Senatore G.
    J Med Chem; 1994 Sep 02; 37(18):2970-5. PubMed ID: 8071944
    [Abstract] [Full Text] [Related]

  • 14. Structure-activity relationships of 8-styrylxanthines as A2-selective adenosine antagonists.
    Jacobson KA, Gallo-Rodriguez C, Melman N, Fischer B, Maillard M, van Bergen A, van Galen PJ, Karton Y.
    J Med Chem; 1993 May 14; 36(10):1333-42. PubMed ID: 8496902
    [Abstract] [Full Text] [Related]

  • 15. Activities of caffeine, theophylline, and enprofylline analogs as tracheal relaxants.
    Brackett LE, Shamim MT, Daly JW.
    Biochem Pharmacol; 1990 Jun 15; 39(12):1897-904. PubMed ID: 2353933
    [Abstract] [Full Text] [Related]

  • 16. Functionalized congeners of 1,3-dipropyl-8-phenylxanthine: potent antagonists for adenosine receptors that modulate membrane adenylate cyclase in pheochromocytoma cells, platelets and fat cells.
    Ukena D, Daly JW, Kirk KL, Jacobson KA.
    Life Sci; 1986 Mar 03; 38(9):797-807. PubMed ID: 3005794
    [Abstract] [Full Text] [Related]

  • 17. 8-Substituted xanthines as antagonists at A1- and A2-adenosine receptors.
    Jacobson KA, de la Cruz R, Schulick R, Kiriasis L, Padgett W, Pfleiderer W, Kirk KL, Neumeyer JL, Daly JW.
    Biochem Pharmacol; 1988 Oct 01; 37(19):3653-61. PubMed ID: 3178879
    [Abstract] [Full Text] [Related]

  • 18. Caffeine analogs: structure-activity relationships at adenosine receptors.
    Daly JW, Hide I, Müller CE, Shamim M.
    Pharmacology; 1991 Oct 01; 42(6):309-21. PubMed ID: 1658821
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological profile of adenosine A2 receptor in PC12 cells.
    Noronha-Blob L, Marshall RP, Kinnier WJ, U'Prichard DC.
    Life Sci; 1986 Sep 22; 39(12):1059-67. PubMed ID: 3018408
    [Abstract] [Full Text] [Related]

  • 20. Sulfur-containing 1,3-dialkylxanthine derivatives as selective antagonists at A1-adenosine receptors.
    Jacobson KA, Kiriasis L, Barone S, Bradbury BJ, Kammula U, Campagne JM, Secunda S, Daly JW, Neumeyer JL, Pfleiderer W.
    J Med Chem; 1989 Aug 22; 32(8):1873-9. PubMed ID: 2754711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.